1. Home
  2. CGEN vs ZEPP Comparison

CGEN vs ZEPP Comparison

Compare CGEN & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • ZEPP
  • Stock Information
  • Founded
  • CGEN 1993
  • ZEPP 2013
  • Country
  • CGEN Israel
  • ZEPP Netherlands
  • Employees
  • CGEN N/A
  • ZEPP N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • ZEPP Computer Manufacturing
  • Sector
  • CGEN Health Care
  • ZEPP Technology
  • Exchange
  • CGEN Nasdaq
  • ZEPP Nasdaq
  • Market Cap
  • CGEN 167.4M
  • ZEPP 148.3M
  • IPO Year
  • CGEN 2000
  • ZEPP N/A
  • Fundamental
  • Price
  • CGEN $1.53
  • ZEPP $11.13
  • Analyst Decision
  • CGEN
  • ZEPP
  • Analyst Count
  • CGEN 0
  • ZEPP 0
  • Target Price
  • CGEN N/A
  • ZEPP N/A
  • AVG Volume (30 Days)
  • CGEN 236.0K
  • ZEPP 1.4M
  • Earning Date
  • CGEN 08-06-2025
  • ZEPP 08-03-2025
  • Dividend Yield
  • CGEN N/A
  • ZEPP N/A
  • EPS Growth
  • CGEN N/A
  • ZEPP N/A
  • EPS
  • CGEN N/A
  • ZEPP N/A
  • Revenue
  • CGEN $27,589,000.00
  • ZEPP $181,183,000.00
  • Revenue This Year
  • CGEN N/A
  • ZEPP $758.69
  • Revenue Next Year
  • CGEN $105.77
  • ZEPP N/A
  • P/E Ratio
  • CGEN N/A
  • ZEPP N/A
  • Revenue Growth
  • CGEN N/A
  • ZEPP N/A
  • 52 Week Low
  • CGEN $1.13
  • ZEPP $2.06
  • 52 Week High
  • CGEN $2.66
  • ZEPP $15.85
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 41.35
  • ZEPP 64.77
  • Support Level
  • CGEN $1.49
  • ZEPP $10.42
  • Resistance Level
  • CGEN $1.64
  • ZEPP $15.85
  • Average True Range (ATR)
  • CGEN 0.08
  • ZEPP 2.13
  • MACD
  • CGEN -0.02
  • ZEPP 0.10
  • Stochastic Oscillator
  • CGEN 25.00
  • ZEPP 60.20

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About ZEPP Zepp Health Corporation

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.

Share on Social Networks: